Fatal pulmonary fibrosis occurring during treatment with cyclophosphamide

Pulmonary fibrosis is an uncommon complication of drug treatment and has been reported in association with many cytotoxic drugs. The authors describe two patients who developed pulmonary fibrosis while receiving cyclophosphamide for glomerulonephritis.

Saved in:
Bibliographic Details
Published in:BMJ 1982-09, Vol.285 (6343), p.696-696
Main Authors: Burke, D A, Stoddart, J C, Ward, M K, Simpson, C G
Format: Article
Language:English
Subjects:
Adult
Biopsies
Bronchoscopy
Cyclophosphamide - adverse effects
Empirical evidence
Fibrosis
Glomerulonephritis
Humans
Male
Middle Aged
Pulmonary alveoli
Pulmonary Alveoli - pathology
Pulmonary fibrosis
Pulmonary Fibrosis - chemically induced
Pulmonary Fibrosis - pathology
Short Reports
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pulmonary fibrosis is an uncommon complication of drug treatment and has been reported in association with many cytotoxic drugs. The authors describe two patients who developed pulmonary fibrosis while receiving cyclophosphamide for glomerulonephritis.
ISSN:0007-1447
0267-0623
0959-8138
1468-5833
DOI:10.1136/bmj.285.6343.696